Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase 2

NCT01694602 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT01694602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01694602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase 2
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
June 30, 2015
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia